Menu

Articles by : William Newton, Associate Editor/Senior Writer

News Alert

Federal Judge Upholds Louisiana’s 340B Contract Pharmacy Law in Another Major Blow to Drug Industry

William Newton, Associate Editor/Senior Writer Views
A federal court upheld Louisiana’s contact pharmacy law this week, drawing praise from provider groups and criticism from the drug industry in the latest of such challenges across the nation.
A federal judge moments ago dismissed three drug industry challenges to Louisiana’s 340B contract pharmacy access law in another major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Breaking News

J&J Abandons 340B Rebate Due to HRSA’s Enforcement Threats But Defends Model in Letter to Agency

William Newton, Associate Editor/Senior Writer Views
J&J announced it will "forgo implementation" of its 340B rebate proposal due to enforcement threats from HRSA.
Johnson & Johnson (J&J) notified the Health Resources and Services Department (HRSA) this morning that it will drop its 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Breaking News

188 Bipartisan House Members Urge HHS Action Against J&J’s ‘Unlawful’ 340B Rebate Proposal

William Newton, Associate Editor/Senior Writer Views
A bipartisan group of 188 House members sent HHS a letter urging action against J&J's 340B rebate proposal.
A bipartisan group of 188 House lawmakers urged the federal government Friday to “use every enforcement tool” at its disposal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Breaking News

HRSA to J&J: End 340B Rebate by Monday or Lose Access to Key Government Health Insurance Markets

William Newton, Associate Editor/Senior Writer Views
HHS and HRSA sent J&J a Sept. 27 letter that again threatened tough enforcement action against the drugmaker's 340B rebate proposal.
The federal agency overseeing the 340B program has doubled down on its threat to terminate Johnson & Johnson’s (J&J’s) access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Exclusive

High-Ranking HRSA Official Talks Genesis Decision, Drugmaker Audits During Rare Unscripted Q&A at Industry Conference

William Newton, Associate Editor/Senior Writer Views
Lisa Scholz interviewed HRSA's OPA Director Chantelle Britton at the MDRP Summit in Chicago.
A high-ranking federal regulator addressed the 340B patient definition and manufacturer audits during an unscripted Q&A session after a speech [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Sanofi Imposes New 340B Contract Pharmacy Rule in Arkansas Following Legal Deal with State

William Newton, Associate Editor/Senior Writer Views
Sanofi Arkansas 340B
Sanofi implemented a new 340B contract pharmacy rule for certain Arkansas hospitals.
Sanofi is requiring Arkansas hospitals to prove they legally own 340B-priced drugs until they are dispensed at contract pharmacies after [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

CMS Publishes Final Rule on Medicaid Rebates with Significant 340B Implications

William Newton, Associate Editor/Senior Writer Views
CMS released a final rule for Medicaid rebates with new identifiers and definitions that impact the 340B program.
Federal regulators last Friday finalized a highly anticipated rule for the Medicaid Drug Rebate Program (MDRP) with new identifiers and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Delaware Enacts 340B-PBM Payment Law Without Contract Pharmacy Provisions from Original Version

William Newton, Associate Editor/Senior Writer Views
Delaware enacted a law prohibiting PBMs from limiting payments to healthcare providers based on their 340B status.
Delaware Gov. John Carney (D) late last week signed into law a bill to prohibit “discrimination against 340B entities by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

PhRMA, HHS Seek Continued Pause on 340B ADR Lawsuit

William Newton, Associate Editor/Senior Writer Views
HHS and PhRMA will continue to pause a lawsuit challenging the government's 340B ADR process.
A major drug industry trade group and the federal government have asked a federal judge to continue to pause litigation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Breaking News

Senator Cassidy Extends 340B Inquiry to Two Major Pharmaceutical Manufacturers

William Newton, Associate Editor/Senior Writer Views
Sen. Bill Cassidy (R-La.) has extended an ongoing 340B probe to two major drug manufacturers.
An influential Republican senator this morning requested detailed information from Eli Lilly and Amgen on their 340B programs, including the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live